New pill for chronic hives and skin disease tested – but study halted early
NCT ID NCT06555328
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an oral drug called INF904 in people with moderate to severe chronic spontaneous urticaria (long-term hives) or hidradenitis suppurativa (a painful skin condition). The trial was open-label and lasted 28 days of treatment plus follow-up. It aimed to check safety and how the drug moves through the body. However, the study was terminated early, so full results are not available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- INF904 (an oral C5aR1 inhibitor)
- What this could lead to
- If successful, INF904 could offer a new oral treatment option for people with chronic hives or hidradenitis suppurativa.
- What could go wrong
- This was an early (Phase 2a) study that was terminated, so results are limited. The drug may not prove effective or safe in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC URTICARIA, IDIOPATHIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
"Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spolka Partnerska"
Wroclaw, 50-566, Poland
-
"Institut Allergieforschung Charité - Universitatsmedizin Berlin"
Berlin, 12203, Germany
-
"Klinikum der Universitat (LMU) Klinik und Poliklinik far Dermatologie und Allergologie"
München, 80337, Germany
-
ASMC IPSMC Skin and Venereal Diseases,
Sofia, 1407, Bulgaria
-
Dawes Fretzin Clinical Research Group, LLC
Indianapolis, Indiana, 46250, United States
-
First OC Dermatology Research Inc.
Fountain Valley, California, 92708, United States
-
ForCare Clinical Research
Tampa, Florida, 33613, United States
-
Forest Hills Dermatology Group
Kew Gardens, New York, 11415, United States
-
General Hospital of Thessaloniki "Papageorgiou"
Thessaloniki, 56403, Greece
-
General University Hospital "Attikon"
Athens, 12462, Greece
-
Katholisches Klinikum Bochum gGmbH/ St.Josef-Hospital Bochum, Dermatologie
Bochum, 44791, Germany
-
Kentucky Advanced Medical Research LLC
Murray, Kentucky, 42071, United States
-
Klinika Dermatologii, Wenerologii i Alergologii, UNIWERSYTECKIE CENTRUM KLINICZNE, ul.
Gdansk, 80-214, Poland
-
LLC "Aversi Clinic"
Tbilisi, 0160, Georgia
-
LLC "Center of Allergy and Immunology"
Tbilisi, 0159, Georgia
-
LTD "Health"
Batumi, 6010, Georgia
-
LTD "Israel-Georgian Medical Research Clinic Healthycore"
Tbilisi, 0112, Georgia
-
Labderm Essence sp.
Ossy, 42-624, Poland
-
MediSearch LLC
Saint Joseph, Missouri, 64506, United States
-
Medical Center Etika
Plovdiv, 4200, Bulgaria
-
Medical Center Excelsior OOD,
Sofia, 1407, Bulgaria
-
Medical Center Medconsult pleven OOD
Pleven, 5800, Bulgaria
-
Medical Center Medconsult, Pleven OOD
Lovech, 5500, Bulgaria
-
Oddziat Kliniczny Wewnetrznych, Astmy i Alergii z Odcinkiem dla Dzieci, Samodzielny Publiczny Zaktad Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny
Lodz, 90-153, Poland
-
Progressive Clinical Research, PA
Texas City, Texas, 78213, United States
-
Universitatsklinikum Dresden Carl Gustav Carus
Dresden, 01307, Germany
-
Universitätsklinikum Frankfurt, Klinik für Dermatologie, Venerologie und Allergologie
Frankfurt, 60950, Germany
-
Wright State Physicians
Fairborn, Ohio, 45324, United States
-
Ziaderm Research LLC
North Miami Beach, Florida, 33162, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could childhood trauma fuel skin inflammation?
- Head-to-Head: which pill tames hidradenitis suppurativa best?
- Skin disease evolution under the microscope: a 17-Year look at what drives severity
- Could early treatment tame a painful skin condition?
- New pill shows promise for controlling painful skin condition in long-term trial
- New shot could ease painful skin condition